Trial Design and Oversight STHLM3-MRI was a prospective, randomized, population-based trial in men 50 to 74 years of age that evaluated various screening strategies for
February 11, 2020, by NCI Staff Traditional radiation therapy (top and bottom left) delivers radiation to the tumor and to healthy tissues around the tumor. With proton